KTOS Form 144: 19,500 Performance Units; 10b5-1 Sales

Kratos Defense & Security Solutions (KTOS) Form 144 filing reports planned resale of 19,500 Performance Stock Units and recent 10b5-1 sales by Phillip Carrai.

Rhea-AI Filing Summary

Kratos Defense & Security Solutions (KTOS) Form 144 filing reports planned resale of 19,500 Performance Stock Units and recent 10b5-1 sales by Phillip Carrai. The filing lists 19,500 securities to be sold (Performance Stock Units dated 02/28/2025) and two executed 10b5-1 sales of 6,500 shares each on 02/17/2026 and 03/16/2026, generating $590,948.80 and $578,947.20 respectively.

Insights

Insider Transactions Analyst

Routine Rule-based dispositions under an established 10b5-1 plan; neutral significance.

The filing documents a resale registration of 19,500 Performance Stock Units and two scheduled 10b5-1 sales by Phillip Carrai totaling 13,000 shares executed on 02/17/2026 and 03/16/2026. The disclosed proceeds are $590,948.80 and $578,947.20.

These entries reflect mechanically executed dispositions under a trading plan rather than discretionary open-market trades; proportionality and remaining holdings are not shown. Subsequent filings will provide additional context on remaining ownership.

Key Figures

Securities to be sold: 19,500 shares 10b5-1 sale - 02/17/2026: 6,500 shares 10b5-1 sale - 03/16/2026: 6,500 shares +1 more

4 metrics

Securities to be sold 19,500 shares Performance Stock Units dated 02/28/2025

10b5-1 sale - 02/17/2026 6,500 shares Proceeds reported as $590,948.80

10b5-1 sale - 03/16/2026 6,500 shares Proceeds reported as $578,947.20

Aggregate executed shares shown 13,000 shares Two 10b5-1 sales of 6,500 shares each

Key Terms

Form 144, 10b5-1 sales, Performance Stock Units

3 terms

Form 144 regulatory

"Lists securities to be sold and recent 10b5-1 sales"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 sales regulatory

"10b5-1 Sales for PHILLIP CARRAI ... 6500 ... 03/16/2026"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Performance Stock Units financial

"Securities To Be Sold ... Performance Stock Units ... 02/28/2025"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does KTOS Form 144 disclose about the securities to be sold?

The filing discloses 19,500 Performance Stock Units listed for resale, dated 02/28/2025. It lists the class as Common stock and the method as resale.

Who executed the recent 10b5-1 sales reported in KTOS Form 144?

Phillip Carrai executed two 10b5-1 sales of 6,500 shares each on 02/17/2026 and 03/16/2026, per the filing.

How much cash was generated by the reported 10b5-1 sales on KTOS Form 144?

The filing shows proceeds of $590,948.80 for the 02/17/2026 sale and $578,947.20 for the 03/16/2026 sale, as reported.

Are the reported transactions on KTOS discretionary trades?

No. The transactions are reported as 10b5-1 sales, indicating they were executed under a pre-established trading plan rather than ad hoc discretionary trades.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 04:50 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001509409
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KRATOS DEFENSE & SECURITY SOLUTIONS, INC.
SEC File Number	001-34460
Address of Issuer	10680 TREENA STREET, SUITE 600 SAN DIEGO CALIFORNIA 92131
Phone	5122389840
Name of Person for Whose Account the Securities are To Be Sold	PHILLIP CARRAI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	19500	1436370.00	170329158	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/28/2025	Performance Stock Units	Issuer			19500	02/28/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PHILLIP CARRAI 10680 TREENA STREET, SUITE 600 SAN DIEGO CA 92131	Common	03/16/2026	6500	578947.20
10b5-1 Sales for PHILLIP CARRAI 10680 TREENA STREET, SUITE 600 SAN DIEGO CA 92131	Common	02/17/2026	6500	590948.80

144: Remarks and Signature

Remarks
Date of Notice	04/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Phillip David Carrai
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)